Emily Salerno

Emily Salerno has extensive work experience in the fields of commercial strategy and operations, consulting, and research.

Emily currently works at Nucleai as the Commercial Strategy & Operations Lead. Nucleai is an AI-powered image analysis and biomarker development company that focuses on transforming pathology data in the development of novel therapies. In their role, Emily leverages real-world datasets containing multi-omics data by partnering with leading medical centers and healthcare providers.

Prior to Nucleai, Emily worked at West Monroe as an Experienced Consultant. Emily later transitioned to the role of Healthcare and Life Science Consultant. West Monroe is a national consulting firm that specializes in technology and works with transformative industries to deliver measurable results. Emily's role involved blending industry expertise with operational and technology capabilities to create quantifiable financial value for clients.

Emily's early work experience includes a role as a Research Assistant at the University at Buffalo (UB). Emily contributed to a research project related to nephrology, specifically focusing on a publication titled "https://jasn. asnjournals. org/content/30/6/979."

Overall, Emily Salerno's work experience highlights their expertise in the fields of commercial strategy and operations, consulting, and research, particularly in healthcare and life sciences.

Emily Salerno received their Bachelor's Degree in Biology from the University of Notre Dame, where they studied from 2015 to 2019. Prior to that, they attended Nardin Academy in Buffalo, NY, although no specific information about their degree or field of study is available.